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Mycobacterium ulcerans infection, known as Buruli ulcer, is a disease of the skin and sub-
cutaneous tissues which is an important but neglected tropical disease with its major impact
in rural parts of West and Central Africa where facilities for diagnosis and management are
poorly developed. We evaluated fluorescent thin layer chromatography (f-TLC) for detection
of mycolactone in the laboratory using samples from patients with Buruli ulcer and patients
with similar lesions that gave a negative result on PCR for the IS2404 repeat sequence of
M. ulcerans
Methodology/Principal findings
Mycolactone and DNA extracts from fine needle aspiration (FNA), swabs and biopsy speci-
men were used to determine the sensitivity and specificity of f-TLC when compared with
PCR for the IS2404. For 71 IS2404 PCR positive and 28 PCR negative samples the sensi-
tivity was 73.2% and specificity of 85.7% for f-TLC. The sensitivity was similar for swabs
(73%), FNAs (75%) and biopsies (70%).
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Conclusions
We have shown that mycolactone can be detected fromM. ulcerans infected skin tissue by
f-TLC technique. The technique is simple, easy to perform and read with minimal costs. In
this study it was undertaken by a member of the group from each endemic country. It is a
potentially implementable tool at the district level after evaluation in larger field studies.
Author Summary
Mycobacterium ulcerans infection, known as Buruli ulcer, is a disease that affects the skin
and underlying tissues. The organism responsible for the infection produces a potent toxin
called mycolactone that causes extensive skin damage. Easy to perform and cheaper tech-
niques are needed for diagnostic confirmation. We have evaluated fluorescent thin layer
chromatography (fTLC) for detection of mycolactone in skin samples from patients with
Buruli ulcer comparing them with samples from similar non-Buruli ulcer lesions that gave
a negative result in the standard polymerase chain reaction (PCR) test forM. ulcerans.
Fluorescent TLC had sensitivity of 73.2% and specificity of 85.7% when compared with
PCR whether the skin sample was a swab, a biopsy or a fine needle aspirate. This study
shows that mycolactone can be detected reliably fromM. ulcerans infected skin tissue by
the simple, low cost technique of fluorescent thin layer chromatography that could be
developed for point of care use. It requires further evaluation in countries where Buruli
ulcer disease is endemic.
Introduction
Mycobacterium ulcerans infection, known as Buruli ulcer, is a disease of the skin and subcuta-
neous tissues which is an important but neglected tropical disease with its major impact in
rural parts of West and Central Africa where facilities for diagnosis and management are
poorly developed [1]. Since prevention is not possible in the absence of either an effective vac-
cine or a clear understanding of the mode of transmission, a major control strategy for Buruli
ulcer is early detection and treatment, hinging on effective laboratory confirmation of sus-
pected cases.
Standard routine laboratory techniques for the confirmation of Buruli ulcer disease areM.
ulcerans isolation by culture, histopathology, smear microscopy for acid-fast bacilli (AFB) and
polymerase chain reaction (PCR) for detection of theM. ulcerans specific insertion sequence
IS2404 [2]. Treatment decisions cannot be made on the basis of culture results becauseM.
ulcerans grows too slowly (over 8–12 weeks) and histopathology is not available in most
endemic countries. Microscopy for AFB can be done quickly at low cost but its sensitivity is
only 40–60% so PCR for IS2404 which has sensitivity of 92–95% has been established as the
gold standard for case confirmation [2] [3] [4]. As PCR is sophisticated and expensive its use
has been restricted to a small number of reference laboratories [5] and numerous studies have
been carried out to develop a simple diagnostic test that can be used at point of care facilities
[6] [7]. One such technique is fluorescent thin layer chromatography (f-TLC) [8] which targets
mycolactone, a polyketide-like toxin produced byM.ulcerans. The toxin, which is not produced
by any other human pathogen, is responsible for the characteristic necrosis inM.ulcerans
infected lesions and it is present in the skin biopsies of mice and humans infected withM.
ulcerans [9] [10] [11].
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Using liquid chromatography-mass spectrometry (LC-MS) mycolactone has been detected in
skin lesions in 77% of patients with untreated Buruli ulcer [11]. Mycolactone can be detected in
human skin samples from patients with Buruli ulcer by conventional TLC as a band at retention
factor value 0.23 but a similar, weaker band was seen in normal human skin [11]. Therefore the
extraction procedure has been modified and a new method has been developed to detect myco-
lactone using 2-naphthylboronic acid to enhance the fluorescence of the molecule [9].
In the present study the new procedure has been evaluated for accuracy in samples from
patients with Buruli ulcer and patients with similar lesions that gave a negative result on PCR
for the IS2404 repeat sequence ofM.ulcerans
Materials and Methods
Patients
Patients were recruited from Buruli ulcer treatment centres from January 2014 to June 2014 in
Benin, DR Congo, Ghana and Côte d’Ivoire if they had a skin lesion suspected to be caused by
M.ulcerans infection. Samples were collected by fine needle aspiration or swab according to
whether the lesion was non-ulcerated or ulcerated respectively and by biopsy if obtained at sur-
gery (Fig 1). If PCR for theM. ulcerans repeat sequence IS2404 was positive they were included
as Buruli ulcer disease patients. If the PCR was negative they were included in the control group.
Sample preparation and shipment
Swabs, fine needle aspirates (FNA) or biopsy were put into O-ring seal plastic vials (Fisher Sci-
entific) containing 1ml absolute ethanol. Vials were wrapped in aluminum foil and kept in the
Fig 1. Clinical forms of Buruli ulcer showing a nodule (A), plaque (B), edema (C) and ulcer (D)
(courtesy of World Health Organization).
doi:10.1371/journal.pntd.0004247.g001
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dark at room temperature. Samples from all the countries were transported to the Harvard lab-
oratory within 3 weeks.
Mycolactone extraction and fluorescent thin layer chromatography
technique
Samples were processed by a modification of the published method [9] (S1 FTLC procedure
and S2 FTLC procedure). Ethanol containing the dissolved sample was filtered through a cot-
ton plug into a glass vial. The sample container was further rinsed with 1 mL ethyl acetate,
which was added to the glass vial through a cotton plug, and the contents were evaporated to
dryness under reduced pressure of about 10-15mmHg using a rotary evaporator (Rotavapor R-
210, Buchi). To separate any contaminating solid from liquid, 100 μL hexane/ether (1:1) solu-
tion was added to the glass vial, rinsed and transferred by micro-syringe into a clean glass vial
which was air-dried. After evaporation, 50 μL hexane/ether (1:1) was added to the dry sample
and 15 μL of the resuspended sample was spotted onto a 3×6 cm fluorescent-dye free TLC
plate (TLC Silica gel 60, EMDMillipore, Darmstadt, Germany; Gibbstown, NJ, USA) alongside
40 ng synthetic mycolactone A/B standard in ethyl acetate and a co-spot of 10 μL sample with
40 ng synthetic mycolactone A/B. The plate was developed in chloroform: hexane: methanol at
a ratio of 5:4:1 until the leading edge reached the top of the plate, air-dried and dipped in 0.1 M
2-naphthylboronic acid solution in acetone, then heated for 60 seconds at 100°C on a hot plate.
The glass side of the plate was wiped with acetone on a paper towel. The plate was placed on a
UV lamp with a 365 nm filter. The fluorescent band at retention factor 0.23 from the patient
sample was compared to that of the standards to confirm the presence of mycolactone. Two
readers were made to confirm the mycolactone test result before test result reporting and were
blinded to the PCR test result.
Polymerase Chain Reaction
Duplicate samples were taken from each patient for PCR targeting theM.ulcerans IS2404
repeat sequence. Samples were processed using the DNA extraction and PCR methods rou-
tinely used in diagnostic confirmation for patient care [12]. The amplification products were
held at 4°C until they were processed further by agarose gel electrophoresis. The method of
PCR included a negative extraction control and positive, negative and inhibition controls.
Statistical analysis
GraphPad Prism 5 software was used for data analysis. Descriptive statistics were used to
obtain general descriptive information such as the mean and ranges from the data. One sample
analysis (Fisher’s exact test) was used to compare two proportions or groups. Contingency
tables were used to calculate the sensitivity, specificity and the predictive values for the various
laboratory techniques employed.
Ethics statement
Ethical approval for the study was obtained from the School of Medical Sciences, Committee
on Human Research, Publication and Ethics (CHRPE/AP/229/12). Written informed consent
was obtained from the patient or their parent/guardian before samples were obtained.
Results
Table 1 shows the characteristics of the patients and the type of sample taken from each. There
were 71 IS2404 PCR positive samples and 28 PCR negative samples which were used as
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controls. The final diagnosis in the control samples is not known. The mean age of patients in
the control group was 41 years compared with 13 years in the Buruli ulcer disease group.
Out of 71 IS2404 PCR positive samples 52 were positive on fluorescent TLC giving a sensi-
tivity of 73.2% (95% CI 61.4–83.1) (Table 2). 4 out of 28 true negatives gave a positive result on
fTLC resulting in the specificity of 85.7% (95% CI 67.3–96.0). Thus 4/57 patients whose sam-
ples were positive by fTLC were false positives (7.0%). The positive predictive value (PPV) was
92.9% (95%CI 82.7–98.0) and the negative predictive value (NPV) 55.8% (95%CI 39.9–70.9).
The sensitivity of fTLC was similar for swabs (73%), FNAs (75%) and biopsies (70%) (Table 3).
Of the 4 false positives, 2 were on the lower limb in patients aged 42 and 62. The clinical
diagnosis of these lesions is unknown and no culture of the underlying organism was per-
formed. The other two were on the arms in a 12 year old male and in a 13 year old female.
Discussion
We have shown that mycolactone can be detected in 73% ofM.ulcerans infected samples by fluo-
rescent thin layer chromatography. The technique was easy to perform and the result could be
read within 1 hour. The sensitivity was higher than that of microscopy (30–60%) or culture (35–
60%) and compared favourably with that of histology (82%)[13, 14]. There was no difference in
sensitivity when FNA and swabs were compared although the number of FNA samples was
small. In this study samples collected in endemic countries over a 3-week period were shipped to
















Table 2. Comparison of results of mycolactone detection by fluorescent TLC with PCR for IS2404.
PCR +ve PCR -ve Total Sensitivity %(95%CI) Speciﬁcity %(95%CI) PPV %(95%CI) NPV %(95%CI)
Mycolactone +ve 52 4 56 73.2 85.7 92.9 55.8




PPV- positive predictive value
NPV- negative predictive value
doi:10.1371/journal.pntd.0004247.t002
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the laboratory at Harvard and stored before testing which may have impacted on the sensitivity
of the assay. This can be investigated by field evaluation of the test in endemic countries.
The specificity was 87% but the implication of four false positives is that 4 patients would
have received treatment for 8 weeks with daily injections of streptomycin and oral rifampicin
with the known potential for side effects associated with those drugs. Two of these patients
were more than 40 years old and had lesions on their lower limbs. Confirmatory PCR would
usually be necessary in this group of patients because the differential diagnosis is broad. How-
ever the other two were children with lesions on upper limb which is more worrying. The cor-
rect diagnosis in these cases is not known and it remains possible that the PCR results were
false negatives. A larger study in which false positives are followed up and diagnosed specifi-
cally is required to resolve this problem. The positive predictive value was 92.9% and the nega-
tive predictive value 55.8% but this needs to be interpreted with caution as samples from
different populations were analysed and the population prevalence was not taken into account.
The extraction efficiency for mycolactone from human tissue is low at 10 to 20% (Caroline
Demangel, personal communication) but fTLC is sensitive enough to detect less than 10ng
mycolactone extracted from a mouse footpad [9]. The number of FNA samples was low in the
present study but mycolactone was detected in these in the same proportion as from swabs and
biopsies. This is an important consideration since more non-ulcerated early lesions are seen
when campaigns to increase awareness of Buruli ulcer are successful.
Development of a diagnostic test forM.ulcerans disease that can be carried out in local treat-
ment centres is a high priority and at a consultative meeting organized by World Health Orga-
nisation/Neglected Tropical Diseases (WHO/NTD) and Foundation for Innovative New
Diagnostics (FIND) in Geneva November 2013 [15], fTLC was identified as a promising tech-
nique with potential for implementation at the district level. Further studies are planned with
the support of FIND andWHO (NTD and TDR) to address the logistics of introducing this
test in endemic countries, to confirm its sensitivity and to investigate its specificity.
Supporting Information
S1 FTLC procedure. Schematic Diagram of F-TLC Analysis of Swab or FNA Samples.
(PDF)
S2 FTLC procedure. Schematic Diagram of F-TLC Analysis of a Biopsy Samples.
(PDF)
Table 3. Sensitivity and specificity by sample type of fluorescent TLC for mycolactone compared to PCR for IS2404.
PCR +ve PCR -ve Total Sensitivity %(95%CI) Speciﬁcity %(95%CI)
Swab
mycolactone +ve 36 2 38 73.4 (58.9–85.1) 86.7 (59.5–99.4)
mycolactone -ve 13 13 26 73.4 (58.9–85.1) 86.7 (59.5–99.4)
FNA
mycolactone +ve 9 0 9 75 (42.8–94.5) 100 (15.8–100)
mycolactone -ve 3 2 5 75 (42.8–94.5) 100 (15.8–100)
Biopsy
mycolactone +ve 7 2 10 70 (34.8–93.3) 60 (40.0–97.2)
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